TAG:
cap
“May 26, 1998 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume V No. 7 – May 26, 1998 Issue
Another pathologybased PPM received venture capital funding. Pathology Consultants of America, (PCA) based in Nashville, Tennessee, just closed a $16 million deal with two venture capitalists. ABS Capital Partners of Baltimore invested $15 million. An affiliate of …
Where Do We Go From Here?
By R. Lewis Dark | From the Volume V No. 6 – May 4, 1998 Issue
THIS IS WRITTEN FOR BOTH LABORATORIANS COMING TO THE DARK REPORT’S Executive War College in New Orleans next week as well as those not attending. As I look at the registration list, I see a diverse range of attendees. Registered for this year’s event are CEOs of public laboratories and…
1997 LIS Sales Rankings Topped By Cerner, LabSoft
By Robert Michel | From the Volume V No. 6 – May 4, 1998 Issue
CEO SUMMARY: Consolidation in the LIS industry continued during 1997. The impact for laboratory buyers is that market share is concentrated among fewer vendors. Over the long term, this reduces choice and leads to an oligopoly-type of market. In the short-term, all LIS companies are compe…
SmithKline, AmeriPath, Quest, Tenet
By Robert Michel | From the Volume V No. 6 – May 4, 1998 Issue
TENET AND MEDPARTNERS CONTINUE TIGHTENING THEIR SO. CALIF. ALLIANCE Remember THE DARK REPORT’S prediction that …
National Labs Show Improved Finances For First Quarter, 1998
By Robert Michel | From the Volume V No. 6 – May 4, 1998 Issue
FIRST QUARTER FINANCIAL performance of the three national laboratories indicates that they may finally be past the worst of the managed care storm. On April 14, Quest Diagnostics Incorporated became the first of the three blood brothers to release earnings. First quarter revenues d…
HMOs Abandon Medicaid In Several Eastern States
By Robert Michel | From the Volume V No. 5 – April 13, 1998 Issue
CEO SUMMARY: In a number of states, certain HMOs have ceased servicing Medicaid patients. This trend will grow. It is the spearpoint for a coming battle between government healthcare programs and private healthcare providers: What level of reimbursement is adequate to provide appropriate …
American Path Resources Bought By Pathology PPM
By Robert Michel | From the Volume V No. 5 – April 13, 1998 Issue
CEO SUMMARY: Here is first confirmation that Pathology Consultants of America has indeed purchased American Pathology Resources. The combination of the two pathology-based physician practice management companies demonstrates that the pathology industry is on the verge of rapid transformat…
Pathology PPM Appears Ready To Hit Marketplace
By Robert Michel | From the Volume V No. 5 – April 13, 1998 Issue
CEO SUMMARY: After several months of delays, Physician Solutions recruited a new CEO and completed arrangements to receive $20 million in venture capital funding. These two milestones mean that the pathology-based physician practice management company will soon be ready to launch formal b…
“April 13, 1998 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume V No. 5 – April 13, 1998 Issue
Last Thursday was the 20th Annual Conference of the Biomedical Marketing Association (BMA). Held in Baltimore, it brought together the marketing and sales executives from diagnostics companies all over the United States. The program focused on changes to how hospitals and laboratorie…
Tennessee Lab Network In Start-Up Preparations
By Robert Michel | From the Volume V No. 4 – March 23, 1998 Issue
CEO SUMMARY: Planning for the Middle Tennessee Healthcare Network’s proposed regional laboratory network took longer than expected, but not without good cause. Organizers of this laboratory network did their homework and created a solid business plan. Approval by CEOs from the participa…
CURRENT ISSUE

Volume XXXII, No. 10 – July 14, 2025
This issue is strong on different flavors of enforcement that clinical laboratories, whether they want to or not, will need to contend with. Lab stakeholders provide insights that medical labs need to brace for more action to counter pending test reimbursement rate cuts under PAMA. Also, this issue provides the legal and regulatory landscape for clinical labs’ use of AI and how it evolves with the technology. AI is creating legal uncertainty for clinical labs, especially around data privacy and FDA oversight of AI tools in diagnostics.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized